Neola Medical

Bergs Securities is proud to have acted as sole manager and bookrunner to Neola Medical in its SEK 32,5 million rights issue.

Neola Medical is a Swedish medical technology company developing Neola®, an innovative non-invasive device for continuous lung monitoring in preterm infants. By providing real-time detection of potentially life-threatening pulmonary complications, the company aims to support earlier clinical intervention, improve neonatal intensive care, and enhance long-term outcomes for vulnerable newborns.